Transgenic Galphaq overexpression induces cardiac contractile failure in mice
about
Protein kinase cascades in the regulation of cardiac hypertrophyIntrinsic-mediated caspase activation is essential for cardiomyocyte hypertrophyTransient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathwaysDeregulation of RGS2 in cardiovascular diseasesScaffold Proteins Regulating Extracellular Regulated Kinase Function in Cardiac Hypertrophy and DiseaseAn experimental approach to study the function of mitochondria in cardiomyopathyGap junction modulation and its implications for heart functionMolecular mechanisms that differentiate apoptosis from programmed necrosisProspects for gene transfer for clinical heart failureNuclear compartmentalization of α1-adrenergic receptor signaling in adult cardiac myocytesGene therapy targets in heart failure: the path to translationThe cell biology of disease: cellular mechanisms of cardiomyopathy."Freeze, Don't Move": How to Arrest a Suspect in Heart Failure - A Review on Available GRK2 InhibitorsPKCepsilon activation induces dichotomous cardiac phenotypes and modulates PKCepsilon-RACK interactions and RACK expressionProtein kinase C epsilon induces systolic cardiac failure marked by exhausted inotropic reserve and intact Frank-Starling mechanismFibroblast growth factor-2 mediates pressure-induced hypertrophic responseTargeted overexpression of ornithine decarboxylase enhances beta-adrenergic agonist-induced cardiac hypertrophyAcyloxy nitroso compounds inhibit LIF signaling in endothelial cells and cardiac myocytes: evidence that STAT3 signaling is redox-sensitiveEffects of G-protein mutations on skin colorThe in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathyPKC alpha regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase1/2 (ERK1/2)Akt-mediated cardiomyocyte survival pathways are compromised by G alpha q-induced phosphoinositide 4,5-bisphosphate depletionRegulation of myocardial function by histidine-rich, calcium-binding proteinEmbryonic cardiomyocyte hypoplasia and craniofacial defects in G alpha q/G alpha 11-mutant mice.Phospholipase Cε hydrolyzes perinuclear phosphatidylinositol 4-phosphate to regulate cardiac hypertrophySerotonin 2B receptor is required for heart developmentRegulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in miceDeletion of low molecular weight protein tyrosine phosphatase (Acp1) protects against stress-induced cardiomyopathy.Conditional expression of a Gi-coupled receptor causes ventricular conduction delay and a lethal cardiomyopathy.Cardiac-specific genetic inhibition of nuclear factor-κB prevents right ventricular hypertrophy induced by monocrotaline.Deep mRNA sequencing for in vivo functional analysis of cardiac transcriptional regulators: application to Galphaq.MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult heartsCytosolic H2O2 mediates hypertrophy, apoptosis, and decreased SERCA activity in mice with chronic hemodynamic overload.Cardiac-specific overexpression of RhoA results in sinus and atrioventricular nodal dysfunction and contractile failure.Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-Jun NH(2)-terminal kinases.RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload.Heterotrimeric G proteins in heart disease.PDE5 inhibitor efficacy is estrogen dependent in female heart disease.Meeting Koch's postulates for calcium signaling in cardiac hypertrophy.MEKK1 is essential for cardiac hypertrophy and dysfunction induced by Gq.
P2860
Q24518494-04AB79FF-54C9-48EC-BDF7-E469464D6F15Q24605583-706645D1-F0F1-472D-88BD-E47CBC46FA2CQ24649132-9A52889B-949E-4A33-B5C6-5FC6299E5874Q24654920-29172250-D41B-48CC-9B3D-C5ECACE14177Q26765993-1CEF11DF-ADD1-4E1E-96C4-D891E80E7172Q26801342-0EE25812-F850-4216-9360-666F3696A539Q26823004-C51F4090-39FB-47F2-987D-AD52A43083BEQ26829092-CEF6FC43-2978-4D85-BB59-7841B3BF45FDQ26830145-692CD112-4A43-4F3D-80E6-5F47D893F29FQ27015977-E114FB45-0ABF-470B-ABF1-7A286A5B9B1DQ27022444-FD8C0DBB-655E-4380-8A65-B73A45A29A5CQ27686758-CE714E91-E529-436E-BC8F-3E42EE008FB3Q28078766-90812AA6-E948-4F46-A34F-22C92CD32D4EQ28200094-C1CA3AAF-432D-4051-B09C-9BCE51C98862Q28256015-76A10401-8081-498D-BB1E-844A60F0F3E7Q28343582-FB29BE33-E83C-4E87-B844-38918AAC426AQ28345192-9DBBD615-C7E7-409E-8DBA-8021D49E55FFQ28482269-8675EF6C-0477-4897-B576-3C9CDAF50BFFQ28509225-EB9DC09E-C302-48D3-BE4F-391B88F09F38Q28510616-488FD8E6-F349-41D1-9738-D65FC0B05906Q28567395-6B11D910-8269-4511-A2AC-126B23F1EB9FQ28571127-CAFED4AC-E229-4425-AF65-A66FB0D5B30DQ28585120-10C89C76-CFCF-4DCA-B394-DDDA8C238A32Q28589329-916AFDF2-1BBA-4210-A816-34D97AB4997FQ28591518-9E7DCD32-12C2-40FC-9AC1-6C617577AAE1Q28594131-EDE2AD58-5529-4627-98B2-050F8C60092EQ28594677-247466BB-781E-4CF3-8FD3-3DF5889FF398Q30032300-78169971-81CE-4ADD-AC83-E6F32068D367Q30479148-2B07C8A3-67B4-4046-BC0B-934EF2A9D21CQ33160867-78A06625-73E3-4F79-9026-C7DF0315544CQ33548600-D09BD4E5-2E66-4272-A278-E7C498087A7DQ33580704-893AE3DC-2DEE-4A34-BA49-5787783E4C5DQ33626525-989ED47C-0B94-4550-A7B1-1E8C6C505B05Q33853316-5B23FBA5-2A34-40CE-90C7-6BB6CE0DD671Q33857393-F0FBD2B8-A676-43A5-8D64-F13CB46BB857Q33857945-FFA4B2C1-C1FE-4BDF-906D-5E2EE1D1A83EQ33865993-7B57A3B3-60E6-4D6E-9AC6-DFD69DBDF050Q33872491-A227CF9F-5DFB-4F31-9BCE-26906E2D281AQ33919182-33227D82-D519-47CC-A860-DEC8AE0C9276Q34020904-53766F65-3830-49B7-9767-73B83C8AAB0A
P2860
Transgenic Galphaq overexpression induces cardiac contractile failure in mice
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Transgenic Galphaq overexpression induces cardiac contractile failure in mice
@ast
Transgenic Galphaq overexpression induces cardiac contractile failure in mice
@en
type
label
Transgenic Galphaq overexpression induces cardiac contractile failure in mice
@ast
Transgenic Galphaq overexpression induces cardiac contractile failure in mice
@en
prefLabel
Transgenic Galphaq overexpression induces cardiac contractile failure in mice
@ast
Transgenic Galphaq overexpression induces cardiac contractile failure in mice
@en
P2093
P2860
P356
P1476
Transgenic Galphaq overexpression induces cardiac contractile failure in mice
@en
P2093
D D D'Angelo
G P Boivin
J N Lorenz
S B Liggett
P2860
P304
P356
10.1073/PNAS.94.15.8121
P407
P577
1997-07-01T00:00:00Z